Effect of estrogen receptor modulator tamoxifen on blood pressure, plasma renin activity, and renal sodium excretion

American Journal of Hypertension

Volumn 15, Issue 8, 2002, Pages 739-742

  Stergiou, George S ^a   Zourbaki, Andromachi S ^a   Efstathiou, Stamatis P ^a   Stathopoulos, George P ^b   Keramopoulos, Antonios D ^c   Mountokalakis, Theodore D ^a  

^a SOTIRIA GENERAL HOSPITAL   (Greece)

^b HIPPOKRATION HOSPITAL   (Greece)

^c ALEXANDRA HOSPITAL   (Greece)

Author keywords

Ambulatory blood pressure monitoring; Blood pressure; Renin; Sodium excretion; Tamoxifen

Indexed keywords

SELECTIVE ESTROGEN RECEPTOR MODULATOR; TAMOXIFEN; ANTIESTROGEN; RENIN; SODIUM;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; BREAST CARCINOMA; CANCER ADJUVANT THERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG WITHDRAWAL; FEMALE; HUMAN; PLASMA RENIN ACTIVITY; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SODIUM EXCRETION; SYSTOLIC BLOOD PRESSURE; URINARY EXCRETION; BLOOD; BLOOD PRESSURE; BLOOD PRESSURE MONITORING; CROSSOVER PROCEDURE; DRUG EFFECT; MIDDLE AGED; URINE;

AGED; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CROSS-OVER STUDIES; ESTROGEN ANTAGONISTS; FEMALE; HUMAN; MIDDLE AGE; POSTMENOPAUSE; RENIN; SODIUM; TAMOXIFEN; HUMANS; MIDDLE AGED;

EID: 0035997364     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(02)02951-5     Document Type: Article

References (19)

1. Menopause and risk of cardiovascular disease: The Framingham study
2. Blood pressure stroke, and coronary heart disease. Part 1, prolonged differences in blood pressure: Prospective observation studies corrected for the regression dilution bias
3. Prevalence of hypertension in the US adult population: Results from the Third National Health and Nutrition Examination Survey, 1988-1991
4. Blood pressure in women taking oral contraceptives
5. Selective oestrogen receptor modulators
6. Role of adjuvant endocrine therapy in early-stage breast cancer
7. Current status of adjuvant endocrine therapy for hormone responsive breast cancer
8. The use of ambulatory blood pressure monitoring to improve accuracy and reduce the number of subjects in clinical trials of antihypertensive agents
9. The two period cross-over clinical study
10. An outline of the revised British Hypertension Society protocol for the evaluation of blood pressure measuring devices
11. Analysis of crossover trial
12. Further analyses of mortality in oral contraceptive users. Royal College of General Practitioners' Oral Contraception Study
13. Association of hormone replacement therapy with various cardiovascular risk factors in postmenopausal women
14. Effects of tamoxifen on cardiovascular risk factors in postmenopausal women
15. Reproducibility of home, ambulatory and clinic blood pressure: Implications for the design of trials for the assessment of antihypertensive drug efficacy
16. Prognostic value of ambulatory blood pressure: Current evidence and clinical implications
17. Gender differences in left ventricular anatomy, blood viscosity and volume regulatory hormones in normal adults
18. Systemic treatment of early breast cancer by hormonal cytotoxic or immune therapy
19. Cardiovascular effects of tamoxifen in women with and without heart disease: Breast cancer prevention trial